Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-07FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's sertraline hydrochloride, a generic version of sertraline, maintaining the u…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: PsilOCD: A Pharmacological-Challenge Feasibility Study [Phase 1]
Phase 1 feasibility study for Obsessive-Compulsive Disorder (PsilOCD) conducted by Imperial College London has completed.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Diagnostic Accuracy of the Stepped Screening Protocol and Its Screening Tools in the Perinatal Period.
An ongoing clinical trial evaluating the diagnostic accuracy of a stepped screening protocol and its tools for perinatal mood and anxiety co…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Deep Brain Stimulation for Obsessive-compulsive Disorder [NA]
A clinical trial update notes that deep brain stimulation for obsessive-compulsive disorder is currently recruiting.
-
FDA approval · 2024-10-17FDA Approved: FLUVOXAMINE MALEATE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for fluvoxamine maleate, providing a generic version of the antidepressant used to treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Virtual Reality System for Anxiety and OCD [NA]
A completed clinical trial evaluating a virtual reality system for anxiety disorders and obsessive-compulsive disorder has posted results on…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder [NA]
A clinical trial comparing inference-based cognitive therapy with exposure and response prevention for obsessive-compulsive disorder; the st…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder [NA]
A clinical trial update for Concentrated Exposure and Response Prevention for children with Obsessive-Compulsive Disorder, sponsored by Upps…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Impact of EsTOCma on OCD Family Members [NA]
A completed clinical trial investigated the impact of EsTOCma on obsessive-compulsive disorder in family members of individuals with OCD.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Online Therapy Youth, Equivalent to Treatment As Usual? [NA]
This clinical trial is recruiting youths to evaluate whether online therapy is equivalent to treatment as usual for depression and trauma-re…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms [NA]
A clinical trial is evaluating the French version of the Metacognitive Bibliotherapy Program (MYMCT) for obsessive-compulsive symptoms in Ob…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Family Involvement in CBGT of OCD: a Randomized Controlled Trial [NA]
A randomized controlled trial is evaluating family involvement in cognitive-behavioral group therapy for Obsessive-Compulsive Disorder and i…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) [Phase 2]
Phase 2 trial evaluating pramipexole or risperidone for refractory obsessive-compulsive disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Light Therapy for Obsessive-compulsive Disorder (OCD) [NA]
A completed clinical trial evaluating light therapy as a treatment for obsessive-compulsive disorder has been completed.
-
FDA approval · 2024-09-13FDA Approved: FLUOXETINE HCL — Original Application (Strides Pharma Science Limited)
FDA approved a generic fluoxetine hydrochloride product from Strides Pharma Science Limited via an original ANDA. The approval confirms the …
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Psilocybin for Treatment of Obsessive Compulsive Disorder [Phase 1]
A completed Phase 1 trial evaluated the safety and tolerability of psilocybin for obsessive-compulsive disorder.
-
FDA approval · 2024-08-29FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved a supplemental application for paroxetine from Modavar Pharmaceuticals LLC.
-
FDA approval · 2024-08-29FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved the supplemental application for Fluoxetine Hydrochloride from Taro Pharmaceuticals U.S.A., Inc. (ANDA211477), enabling the mar…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Reinforcement Learning and Obsessive-compulsive Disorder: Exploring the Role of the Orbitofrontal Cortex
A clinical trial investigating reinforcement learning and the orbitofrontal cortex in obsessive-compulsive disorder. The study is currently …
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment [NA]
A completed longitudinal fMRI study investigating neuroimaging biomarkers in anxiety disorder and obsessive-compulsive disorder with Paroxet…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Chart Review of Patients Undergoing Ketamine Infusions
A completed chart-review study of patients undergoing ketamine infusions for major depressive disorder, bipolar disorder, obsessive-compulsi…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil [NA]
A Brazilian clinical trial is evaluating Acceptance and Commitment Therapy in group sessions for Obsessive-Compulsive Disorder. The study is…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation [NA]
A clinical trial update for obsessive-compulsive disorder examining local field potential biomarkers for deep brain stimulation, currently r…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
This clinical trial update notes the completion of a study exploring the neurobiology of sensory phenomena in obsessive-compulsive disorder.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of agomelatine in patients with obsessive-compulsive disorder has completed.